Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Sep 3, 2025 | McIntyre Partnerships | -2.1% | -18.9% | SEG MM, SHC | Balance Sheets, Intrinsic Value, Mean reversion, Patience, value | The letter emphasizes patient value investing focused on buying high-quality businesses at discounts created by short-term dislocations. Management highlights disciplined capital allocation, conservative balance sheets, and long holding periods. Value realization is expected through normalization of earnings and multiple expansion over time. | SEG SHC |
View |
| 2024 Q1 | May 31, 2024 | McIntyre Partnerships | 14.7% | 6.0% | CC, SHC | - | View | ||
| 2025 Q1 | May 13, 2025 | McIntyre Partnerships | -17.1% | -17.1% | GTX, MDRX, SHC | - | View | ||
| 2024 Q1 | Apr 15, 2024 | Meridian Growth Fund | 6.8% | 0.0% | ACVA, IRDM, QDEL, RBRI, SHC, TRMB | - | View | ||
| 2024 Q4 | Feb 3, 2025 | McIntyre Partnerships | -5.6% | 0.0% | GTX, SHC, STHO | - | View | ||
| 2025 Q4 | Feb 19, 2026 | McIntyre Partnerships | 0.0% | 6.0% | MDRX, SAFE, SHC, STE | healthcare, liquidation, real estate, small cap, undervalued, value | Portfolio positioned in undervalued securities trading at significant discounts to intrinsic value. Manager emphasizes rotation from winners to laggards where fundamentals are improving but share prices declined. Focus on companies with strong cash generation trading below fair value multiples. Significant exposure to healthcare through sterilization services (SHC) and healthcare software (MDRX). Healthcare IT viewed as defensive with regulatory complexity creating barriers to disruption. Sterilization services seen as recession-proof with predictable growth. Exposure through liquidating real estate holdings (STHO) and entertainment real estate (SEG). Focus on asset monetization and development projects with major tenants like Meow Wolf driving traffic and rental income growth. | MDRX SEG STHO SHC |
View |
| 2024 Q3 | Nov 7, 2024 | Prosper Stars & Stripes | -2.0% | - | BIO, BLFS, CRS, DOCS, FND, NR, PCT, SHC, UPWK, WEX | - | View | ||
| 2023 Q2 | Oct 8, 2023 | McIntyre Partnerships | 14.7% | 6.0% | GTX, SHC | - | View | ||
| 2024 Q2 | Jul 31, 2024 | McIntyre Partnerships | 14.7% | 6.0% | SHC | - | View | ||
| 2022 Q4 | Jan 27, 2023 | McIntyre Partnerships | 14.7% | 6.0% | MSGE, SHC, STE | - | View | ||
| 2023 Q4 | Jan 24, 2024 | McIntyre Partnerships | 14.7% | 6.0% | GTX, MSGE, SHC, SPHR | - | View | ||
| 2023 Q1 | Jan 5, 2023 | McIntyre Partnerships | 14.7% | 6.0% | OSW, SHC, SPHR, STHO | - | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Fund Letters | Chris McIntyre | Sotera Health Company | Health Care | Health Care Services | Bull | NASDAQ | duopoly, EBITDA, healthcare, litigation, Sterilization, Tax rate | View Pitch |
| Jan 8, 2026 | Fund Letters | Chris McIntyre | Sotera Health Co. | Health Care | Health Care Services | Bull | New York Stock Exchange | compounding, Medtech, Re-rating, Sterilization, Volumes | View Pitch |
| Aug 7, 2025 | Seeking Alpha | Bret Jensen | Sotera Health Company | Health Care | Diagnostics & Research | Neutral | NASDAQ | — | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||